| View |
|
BR-1319
|
Follitropin alfa / Lutropin alfa
|
Pergoveris
|
450 IU/225 IU (0.72 mL)
|
Solution For Injection (SC)
|
Prescription Drug (Rx)
|
Multidose. 3 mL EP/USP Type I pre-filled pen + 7 296 x 12" double-ended needles in a Box.
|
-
|
Merck Serono S.p.A
|
Italy
|
N/A
|
Merck, Inc.
|
Merck, Inc.
|
Variation
|
11 June 2021
|
16 April 2025
|
| View |
|
BR-1320
|
Follitropin alfa / Lutropin alfa
|
Pergoveris
|
900 IU/450 IU (1.44 mL)
|
Solution For Injection (SC)
|
Prescription Drug (Rx)
|
Multidose. 3 mL EP/USP Type I pre-filled pen + 14 29Gx" double-ended needles in a Box.
|
-
|
Merck Serono S.p.A.
|
Italy
|
N/A
|
Merck, Inc.
|
Merck, Inc.
|
Variation
|
11 June 2021
|
16 April 2025
|
| View |
BR-1321_PI_01.pdf
|
BR-1321
|
Botulinum Toxin Type A
|
Nabota
|
200 Units
|
Lyophilized Powder for Solution for Injection (IM/SC)
|
Prescription Drug (RX)
|
USP Type O borosilicate glass vial enclosed with chlorobutyl rubber stopper, crimped with aluminum seal and orange polypropylene cap (Box of 1's)
|
-
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
|
Daewoong Pharma Philippines, Incorporated
|
|
Monitored Release
|
16 June 2020
|
16 June 2025
|
| View |
BR-1323_PI_01.pdf
|
BR-1323
|
Adalimumab
|
Humira
|
20mg/0.2mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
1 Box holds 2 Alcohol swabs and 2 blister, each containing type 1 pre-filled glass syringe x 0.2mL with 29 G 1/2 Needle. Single dose.
|
-
|
Vetter Pharma-Fertigung GmbH & Co. KG
|
Germany
|
|
Zuellig Pharma Corporation
|
|
monitored Release
|
24 June 2020
|
24 June 2025
|
| View |
BR-1324_PI_01.pdf
|
BR-1324
|
Somatropin
|
Genotropin GoQuick
|
12 mg/mL
|
Powder and Solvent for Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Packaging:
Two-chamber glass cartridge (Type I) containing powder and 1 mL solvent separated by a rubber plunger (bromobutyl). The cartridge is sealed at one end with a rubber disc (bromobutyl) and an aluminum cap and at the other end by a rubber stopper (bromobutyl). The two-chamber cartridge is supplied for use in a disposable multidose pre-filled pen. (Box of 1's)
|
Anterior Pituitary Lobe Hormones and Analogues
|
Pfizer Manufacturing Belgium N.V.
|
Belgium
|
|
Pfizer, Inc.
|
|
Monitored Release (MR) (Reconstruction) `
|
22 February 2024
|
16 July 2025
|
| View |
BR-1325_PI_01.pdf
|
BR-1325
|
Somatropin
|
Genotropin GoQuick
|
5.3mg/mL
|
Powder and Solvent for Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Two-chamber glass cartridge (Type I) containing powder and 1 mL solvent separated by a rubber plunger (bromobutyl). The cartridge is sealed at one end with a rubber disc (bromobutyl) and an aluminum cap and at the other end by a rubber stopper (bromobutyl). The two-chamber cartridge is supplied for use in a disposable multidose pre-filled pen. (Box of 1's)
|
Anterior Pituitary Lobe Hormones and Analogues
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
|
Pfizer, Inc.
|
|
Monitored Release (MR) (Reconstruction) `
|
22 February 2024
|
16 July 2025
|
| View |
BR-1326_PI_01.pdf
|
BR-1326
|
Semaglutide
|
Ozempic
|
1 mg/0.74mL (1.34mg/mL)
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
Multiple dose. 3 mL Type I glass cartridge with chlorobutyl rubber plunger and aluminum cap with a laminated rubber sheet assembled in disposable blue. PDS290 pen-injector with a dose adjustment of 74 increments +4 Novofine Plus 32G 4 mm needles (Box of 1's)
|
-
|
Novo Nordisk A/S
|
Denmark
|
N/A
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Monitored Release (Variation)
|
17 November 2022
|
17 November 2027
|
| View |
BR-1327_PI_01.pdf
|
BR-1327
|
Semaglutide
|
Ozempic
|
0.5 mg/0.37 mL (1.34 mg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
Multiple dose. 1.5 mL Type I glass cartridge with chlorobutyl rubber plunger and aluminum cap with a laminated rubber sheet assembled in blue PDS290 pen injector + 4 Novofine Plus 32G 4 mm needles (Box of l's)
|
-
|
Novo Nordisk A/S
|
Denmark
|
N/A
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Monitored Release (Variation)
|
28 October 2022
|
28 October 2027
|
| View |
BR-1328_PI_01.pdf
|
BR-1328
|
Semaglutide
|
Ozempic
|
0.25 mg/0.19 mL (1.34 mg/mL)
|
Solution for Injection
(SC)
|
Prescription Drug (RX)
|
Multiple dose. 1.5 mL Type I glass cartridge with
chlorobutyl rubber plunger and aluminum cap with a laminated rubber sheet assembled in blue PDS290 pen-injector with a dose adjustment of 19 increments + 4 Novofine Plus 32G 4 mm needles (Box of 1's).
|
-
|
Novo Nordisk A/S
|
Denmark
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
-
|
29 September 2020
|
29 September 2025
|
| View |
BR-1330_PI_01.pdf
|
BR-1330
|
Guselkumab
|
Tremfya
|
100 mg
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
1 mL Type I prefilled glass syringe with gray
bromobutyl rubber and teal plunger rod and a fixed 276 x 1" needle enclosed in a latex-free rigid needle shield (Box of l's)
|
-
|
Cilag AG
|
Switzerland
|
|
Johnson & Johnson (Philippines), Inc.
|
Johnson & Johnson (Philippines), Inc.
|
-
|
21 October 2020
|
21 October 2025
|
| View |
|
BR-1331
|
Emicizumab
|
Hemlibra
|
30 mg/ mL
|
Solution For Injection SC
|
Prescription Drug (RX)
|
3 mL Type I colorless glass vial with grey butyl
rubber stopper sealed with aluminum cap fitted with
sky blue plastic flip-off disk (Box of l's)
|
-
|
Chugai Pharma Manufacturing Co., Ltd. (Utsunomiya
Plant)
|
Japan
|
F. Hoffman-La Roche Ltd.
|
Roche (Philippines), Inc.
|
Roche (Philippines), Inc.
|
Monitored Release
|
14 December 2020
|
14 December 2025
|
| View |
|
BR-1332
|
Emicizumab
|
Hemlibra
|
60 mg/ 0.4 mL
|
Solution For Injection SC
|
Prescription Drug (RX)
|
3 mL Type I colorless glass vial with grey butyl
rubber stopper sealed with aluminum cap fitted with
purple plastic flip-off disk (Box of l's)
|
-
|
Chugai Pharma Manufacturing Co., Ltd. (Utsunomiya
Plant)
|
Japan
|
F. Hoffman-La Roche Ltd.
|
Roche (Philippines), Inc.
|
Roche (Philippines), Inc.
|
Monitored Release
|
14 December 2020
|
14 December 2025
|
| View |
|
BR-1333
|
Emicizumab
|
Hemlibra
|
105 mg/ 0.7 mL
|
Solution For Injection SC
|
Prescription Drug (RX)
|
3 mL Type I colorless glass vial with grey butyl
rubber stopper sealed with aluminum cap fitted with
turquoise plastic flip-off disk (Box of l’s)
|
-
|
Chugai Pharma Manufacturing Co., Ltd. (Utsunomiya
Plant)
|
Japan
|
F. Hoffman-La Roche Ltd.
|
Roche (Philippines), Inc.
|
Roche (Philippines), Inc.
|
Monitored Release
|
14 December 2020
|
14 December 2025
|
| View |
|
BR-1334
|
Emicizumab
|
Hemlibra
|
150 mg/ mL
|
Solution For Injection SC
|
Prescription Drug (RX)
|
3 mL Type I colorless glass vial with grey butyl
rubber stopper sealed with aluminum cap fitted with
brown plastic flip-off disk (Box of 1's)
|
-
|
Chugai Pharma Manufacturing Co., Ltd. (Utsunomiya
Plant)
|
Japan
|
F. Hoffman-La Roche Ltd.
|
Roche (Philippines), Inc.
|
Roche (Philippines), Inc.
|
Monitored Release
|
14 December 2020
|
14 December 2025
|
| View |
|
BR-1337
|
Bevacizumab
|
Mvasi
|
400 mg/16 mL (25 mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
Prescription Drug (Rx)
|
20 mL USP/EP Type I clear, colorless glass vial with light gray elastomeric stopper and blue aluminum seal with green polypropylene flip-off cap (Box of l's)
|
-
|
Amgen Manufacturing Limited
|
USA
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial
|
28 January 2021
|
28 January 2026
|
| View |
|
BR-1340
|
Follitropin Delta
|
Rekovelle
|
72 mcg/2.16 mL (33.3 mcg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL (Net content: 2.16 mL) Borosilicate Type I glass
cartridge with bromobutyl rubber plunger, enclosed with aluminum crimp cap and bilayer polyisoprene/ bromobutyl rubber. The cartridge is assembled in a disposable polypropylene pen (Box of l's). 9 Separate Clickfine 296 x 12 mm pen needles are included.
|
-
|
Vetter Pharma-Fertigung
|
Germany
|
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
-
|
10 February 2021
|
10 February 2026
|
| View |
|
BR-1341
|
Follitropin Delta
|
Rekovelle
|
36 mcg/1.08 mL (33.3 mcg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL (Net content: 1.08 mL) Borosilicate Type I glass cartridge with bromobutyl rubber plunger, enclosed with aluminum crimp cap and bilayer polyisoprenel bromobutyl rubber. The cartridge is assembled in a disposable polypropylene pen (Box of 1's). 6 Separate Clickfine 296 x 12 mm pen needles are included.
|
-
|
Vetter Pharma-Fertigung
|
Germany
|
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
-
|
10 February 2021
|
10 February 2026
|
| View |
|
BR-1342
|
Follitropin Delta
|
Rekovelle
|
12 mcg/0.36 mL (33.3 mcg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL (Net content: 0.36 mL) Borosilicate Type I glass cartridge with bromobutyl rubber plunger, enclosed with aluminum crimp cap and bilayer polyisoprene/ bromobutyl rubber. The cartridge is assembled in a disposable polypropylene pen (Box of l’s). 3 Separate Clickfine 296 x 12 mm pen needles are included.
|
-
|
Vetter Pharma-Fertigung
|
Germany
|
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
-
|
10 February 2021
|
10 February 2026
|
| View |
|
BR-1343
|
Etanercept
|
Enbrel
|
50mg/mL
|
Solution For Injection (S.C.)
|
Prescription Drug (Rx)
|
1 mL EP Type I prefilled glass syringe with grey bromobutyl rubber plunger, white polypropylene plunger rod and 27G staked-in needle with needle shield (4 PFS + 4 alcohol pads per blister tray) (Box of 4's)
|
-
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
N/A
|
Pfizer, Inc.
|
Pfizer, Inc.
|
Initial
|
15 March 2021
|
11 March 2026
|
| View |
|
BR-1344
|
Etanercept
|
Enbrel
|
25 mg/0.5 mL
|
Solution For Injection (S.C.)
|
Prescription Drug (Rx)
|
1 mL EP Type 1 Pre-filled Glass Syringe with Grey Bromobutyl Rubber Plunger, White Polypropylene Plunger Rood and 27G Staked-in Needle with Needle Shield (4 PFS + 4 Alcohol Pads per Blister Tray)
|
-
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
N/A
|
Pfizer, Inc.
|
Pfizer, Inc.
|
Variation
|
11 March 2022
|
11 March 2026
|